The Indianapolis Colts believe heavily in the value of the Senior Bowl, as they have routinely drafted multiple players from the event each year in Chris Ballard's tenure as general manager.

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

INDIANAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025. Lilly will also ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... On January 18, Robert Pavlik, senior portfolio manager at Dakota Wealth Management, appeared in an interview ...

WISH-TV/WNDY located in Indianapolis, IN has an immediate opening for an experienced, technically minded, innovative Senior Newscast Director. The ideal candidate will be a highly experienced ...

Zoho CEO Sridhar Vembu backs IIT Madras Director Prof. V Kamakoti's claims on the medicinal properties of cow urine or gomutra. In a post on the social media platform X, Vembu wrote, "This nation ...

Update: A previous version of the story erroneously claimed that the global CMO has also left the company. The corrected version follows. George Zhao resigned as Honor's CEO last week, prompting ...

One of McKinsey & Company's top executives is leaving the firm for Silicon Valley's new promised land: the AI industry. After 12 years at McKinsey, Matthew Fitzpatrick, senior partner and global ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

The stage may be set for a reversal or move higher. Next: Access Our New, Shockingly Simple 'Alert System' Shares of Eli Lilly and Company LLY are trading higher after getting pummeled on Friday.